RefE-624

Entered

Figures4 min · 873 words

Working paper

USA Rare Earth Misses Estimates as Shortages Constrain Production

USA Rare Earth lost $0.44 a share against a $0.19 consensus on $3.0 million in revenue, as higher expenses, material shortages and a delayed Round Top report offset early commercial shipments.

Exhibit AUSA Rare Earth (NASDAQ:USAR) Shares Gap Down on Disappointing Earnings
USA Rare Earth (NASDAQ:USAR) Shares Gap Down on Disappointing Earnings — Pexels / pixabay

USA Rare Earth Inc. (NASDAQ: USAR) reported a quarterly loss of $0.44 per share, $0.25 worse than the $0.19 consensus, on revenue of $3.00 million.

Shares gapped down before Tuesday’s market open, opening at $8.26 against the prior $8.76 close. They last traded at $8.3580 on volume of 4,356,481 shares. Disappointing earnings supplied the stated catalyst, although the figures do not isolate how much of the move came from company news rather than broader trading.

What pushed the quarter below estimates?

Higher expenses widened the loss, and raw-material shortages constrained production. Management also delayed the Round Top report to Q3 2027. Earnings-call coverage flagged increased cash burn without quantifying it.

Against those negatives, USA Rare Earth reported $1.2 billion in cash. The balance shows substantial liquidity, but the disclosure does not show how quickly operating and project spending will consume it.

The cash cushion buys time, but the quarter still ended with a loss, constrained production and a delayed report.

What has already reached the market?

USA Rare Earth began commercial-scale shipments of heavy rare earth mixed carbonate from Serra Verde. First sales came in November under a 15-year offtake agreement. The company targets an initial run rate of about 4,000 tonnes per year by Q2 2027.

The shipment confirms commercial activity, but the run-rate target remains forward-looking. The figures provide no shipment value or revenue contribution, and nothing establishes that the company will reach the target.

The company also delivered its first yttrium oxide samples to a major defense, medical and specialty-coatings customer for preliminary testing and prototyping. Those samples could broaden commercial opportunities, but they are not confirmed production orders, and the company disclosed no commercial value for them.

Commercial cargo and test samples show progress, but neither yet demonstrates a repeatable earnings stream.

How do analyst targets frame the debate?

  • Cantor Fitzgerald retained an “overweight” rating on Tuesday while cutting its target from $40 to $30. The $30 target still implied substantial upside from the reported $8.76 share price, though a target remains an estimate rather than a guarantee.
  • Weiss Ratings reissued a “sell (d-)” rating on Wednesday, November 4.
  • Roth Capital cut its target from $40 to $30 on Tuesday, July 21 while assigning a buy rating.
  • Texas Capital upgraded the shares to strong-buy on Tuesday, October 20.
  • Jefferies Financial Group initiated coverage on Wednesday, September 2 with a buy rating and a $21 price objective.

MarketBeat.com data list one Strong Buy, nine Buy ratings and one Sell. The consensus rating was Moderate Buy, with a $32.29 target. That spread shows genuine disagreement, and consensus does not resolve the company’s production and spending risks.

Which institutions added positions?

  • BlackRock Inc. bought a new second-quarter position worth about $335,795,000.
  • Weiss Asset Management LP acquired a new first-quarter stake worth about $17,103,000.
  • Encompass Capital Advisors LLC acquired a new first-quarter stake worth about $7,038,000.
  • Man Group plc acquired a new second-quarter stake worth about $2,562,000.
  • Overbrook Management Corp acquired a new third-quarter position valued at $3,145,000.

Reported buying shows ownership, not the investors’ rationale, and it does not guarantee additional demand. Institutional exposure and the company’s cash burn remain separate facts.

What business sits behind the numbers?

USA Rare Earth carries a $2.01 billion market capitalization, a P/E ratio of -3.41 and a beta of 2.79. Its 50-day moving average is $13.04, and its 200-day average is $18.53; both exceed the $8.3580 last trade. The beta signals above-market volatility, while moving averages describe past prices rather than establish a future direction.

The company is developing a U.S.-focused supply chain for rare earth materials and permanent magnets used in electric vehicles, wind turbines, electronics, aerospace and defense. Its planned activities span mineral extraction, materials processing and magnet manufacturing. That breadth defines the strategy, but planned capacity does not establish current output.

At Round Top in West Texas, the company is advancing a deposit containing rare earth elements and other minerals used in advanced technologies. It describes the deposit as a potential source of light and heavy rare earths, important inputs for high-performance magnets and other industrial products. The Round Top report now points to Q3 2027, and the company still describes the deposit only as a potential source of those materials.

USA Rare Earth is also developing magnet manufacturing in Stillwater, Oklahoma, and owns Less Common Metals, a U.K.-based producer of rare-earth metals and alloys.

Round Top, Stillwater and Less Common Metals give the company assets across the supply chain, but operating data from each stage remain necessary to judge that reach.

What must happen next?

Can commercial shipments lift revenue above $3.00 million, can output reach the 4,000-tonne annual run rate by Q2 2027, and will management provide the Round Top report in Q3 2027? Until those data arrive, $1.2 billion in cash shows substantial liquidity, while the $0.44 loss, constrained production and higher cash burn remain the harder facts.

Audit trail

  1. Quarterly loss was $0.44 per share versus a $0.19 consensus; revenue was $3.00 million.
  2. Shares opened at $8.26 after a $8.76 close and last traded at $8.3580 on 4,356,481 shares.
  3. Commercial-scale carbonate shipments began; the target is about 4,000 tonnes annually by Q2 2027.
  4. The company reported $1.2 billion in cash and delayed the Round Top report to Q3 2027.
  5. Analyst consensus was Moderate Buy with a $32.29 target; one Strong Buy, nine Buy and one Sell were recorded.

via dailypolitical.com (Source)

Filed under

  • usa-rare-earth
  • quarterly-earnings
  • rare-earth-supply-chain
  • production-constraints
  • round-top
Share this article:

More from Tom Whitfield

Tom Whitfield

Show full bio

News editor covering companies, deals and strategy in corporate finance and the leaders who run it at CFO Observer.

125 articles

Cross-references

« Previous articleNext article »